INDOUSNSEIndo Us Biotech LimitedMediumNeutral
Announced Wed, 22 Apr · 17:15 IST

Indo Us Biotech Limited has informed the Exchange regarding Change in Director(s) of the company.

Management Changes View source PDF

INDOUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.3%1-day move
₹107.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.3-3.3-4.7-2.8-2.2-3.0-2.3-6.0-16.2-19.8
Up moveDown movePending
AI summary

Indo Us Biotech Limited has appointed Mrs. Hemanshi Darsh Soni (DIN: 11659183) as an Additional Director in the capacity of Non-Executive Independent Director, effective from April 21, 2026, for a period of 5 years, subject to shareholder approval. She is not related to any existing Director or Key Managerial Personnel of the company. Her brief profile mentions experience in the service sector with expertise in building high-performance teams, sales, marketing, and operational processes. She does not hold directorship in any other listed entity and is not debarred by SEBI or any other authority. The company clarified that this is a revised intimation in response to a query from the exchange dated April 22, 2026.

Likely market impact

This is a routine corporate governance update — the addition of an independent director strengthens board composition. No material impact on the stock price is expected from this appointment alone.